Logo image of CCEP.AS

COCA-COLA EUROPACIFIC PARTNE (CCEP.AS) Stock Fundamental Analysis

AMS:CCEP - Euronext Amsterdam - GB00BDCPN049 - Common Stock - Currency: EUR

80.8  +0.9 (+1.13%)

Fundamental Rating

4

Overall CCEP gets a fundamental rating of 4 out of 10. We evaluated CCEP against 25 industry peers in the Beverages industry. There are concerns on the financial health of CCEP while its profitability can be described as average. CCEP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year CCEP was profitable.
In the past year CCEP had a positive cash flow from operations.
In the past 5 years CCEP has always been profitable.
CCEP had a positive operating cash flow in each of the past 5 years.
CCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFCCEP.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.56%, CCEP is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
CCEP has a better Return On Equity (16.70%) than 80.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.00%, CCEP is in line with its industry, outperforming 56.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CCEP is in line with the industry average of 7.98%.
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROIC 7%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP.AS Yearly ROA, ROE, ROICCCEP.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CCEP's Profit Margin of 6.94% is in line compared to the rest of the industry. CCEP outperforms 48.00% of its industry peers.
In the last couple of years the Profit Margin of CCEP has declined.
Looking at the Operating Margin, with a value of 10.46%, CCEP is doing worse than 68.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CCEP has declined.
With a Gross Margin value of 35.31%, CCEP is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CCEP has remained more or less at the same level.
Industry RankSector Rank
OM 10.46%
PM (TTM) 6.94%
GM 35.31%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP.AS Yearly Profit, Operating, Gross MarginsCCEP.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

CCEP has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CCEP has more shares outstanding
CCEP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CCEP has been reduced compared to a year ago.
CCEP.AS Yearly Shares OutstandingCCEP.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP.AS Yearly Total Debt VS Total AssetsCCEP.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CCEP has an Altman-Z score of 2.17. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.17, CCEP is in line with its industry, outperforming 60.00% of the companies in the same industry.
The Debt to FCF ratio of CCEP is 5.34, which is a neutral value as it means it would take CCEP, 5.34 years of fcf income to pay off all of its debts.
CCEP's Debt to FCF ratio of 5.34 is amongst the best of the industry. CCEP outperforms 88.00% of its industry peers.
A Debt/Equity ratio of 1.17 is on the high side and indicates that CCEP has dependencies on debt financing.
CCEP has a Debt to Equity ratio (1.17) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Altman-Z 2.17
ROIC/WACC0.94
WACC7.43%
CCEP.AS Yearly LT Debt VS Equity VS FCFCCEP.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CCEP has a Current Ratio of 0.81. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP has a worse Current ratio (0.81) than 68.00% of its industry peers.
CCEP has a Quick Ratio of 0.81. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP's Quick ratio of 0.62 is in line compared to the rest of the industry. CCEP outperforms 52.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.62
CCEP.AS Yearly Current Assets VS Current LiabilitesCCEP.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CCEP have decreased strongly by -15.31% in the last year.
Measured over the past 5 years, CCEP shows a small growth in Earnings Per Share. The EPS has been growing by 5.80% on average per year.
The Revenue has grown by 11.67% in the past year. This is quite good.
The Revenue has been growing by 11.21% on average over the past years. This is quite good.
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%

3.2 Future

The Earnings Per Share is expected to grow by 9.67% on average over the next years. This is quite good.
CCEP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.45% yearly.
EPS Next Y5.49%
EPS Next 2Y7.39%
EPS Next 3Y7.98%
EPS Next 5Y9.67%
Revenue Next Year3.24%
Revenue Next 2Y3.41%
Revenue Next 3Y3.58%
Revenue Next 5Y3.45%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCEP.AS Yearly Revenue VS EstimatesCCEP.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
CCEP.AS Yearly EPS VS EstimatesCCEP.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.32, CCEP can be considered very expensive at the moment.
Based on the Price/Earnings ratio, CCEP is valued a bit more expensive than the industry average as 64.00% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 26.34. CCEP is around the same levels.
With a Price/Forward Earnings ratio of 19.11, CCEP is valued on the expensive side.
CCEP's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CCEP is more expensive than 68.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, CCEP is valued at the same level.
Industry RankSector Rank
PE 26.32
Fwd PE 19.11
CCEP.AS Price Earnings VS Forward Price EarningsCCEP.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCEP is valued a bit more expensive than 76.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CCEP is valued a bit cheaper than 68.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.53
EV/EBITDA 15.06
CCEP.AS Per share dataCCEP.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCEP does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.8
PEG (5Y)4.54
EPS Next 2Y7.39%
EPS Next 3Y7.98%

More info and screens

3

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.39%. Purely for dividend investing, there may be better candidates out there.
CCEP's Dividend Yield is comparable with the industry average which is at 2.89.
CCEP's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.39%

5.2 History

On average, the dividend of CCEP grows each year by 9.91%, which is quite nice.
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP.AS Yearly Dividends per shareCCEP.AS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CCEP pays out 64.17% of its income as dividend. This is not a sustainable payout ratio.
CCEP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP64.17%
EPS Next 2Y7.39%
EPS Next 3Y7.98%
CCEP.AS Yearly Income VS Free CF VS DividendCCEP.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP.AS Dividend Payout.CCEP.AS Dividend Payout, showing the Payout Ratio.CCEP.AS Dividend Payout.PayoutRetained Earnings

More info and screens

COCA-COLA EUROPACIFIC PARTNE

AMS:CCEP (6/20/2025, 2:39:03 PM)

80.8

+0.9 (+1.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)04-29 2025-04-29
Earnings (Next)N/A N/A
Inst Owners37.53%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap37.19B
Analysts77.27
Price Target84.81 (4.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.39%
Yearly Dividend1.98
Dividend Growth(5Y)9.91%
DP64.17%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.17%
PT rev (3m)-2.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.11%
Valuation
Industry RankSector Rank
PE 26.32
Fwd PE 19.11
P/S 1.82
P/FCF 17.53
P/OCF 12.15
P/B 4.38
P/tB N/A
EV/EBITDA 15.06
EPS(TTM)3.07
EY3.8%
EPS(NY)4.23
Fwd EY5.23%
FCF(TTM)4.61
FCFY5.71%
OCF(TTM)6.65
OCFY8.23%
SpS44.4
BVpS18.44
TBVpS-19.44
PEG (NY)4.8
PEG (5Y)4.54
Profitability
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROCE 9.32%
ROIC 7%
ROICexc 7.57%
ROICexgc 42.27%
OM 10.46%
PM (TTM) 6.94%
GM 35.31%
FCFM 10.38%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexcg growth 3Y8.99%
ROICexcg growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Debt/EBITDA 3.24
Cap/Depr 100.64%
Cap/Sales 4.59%
Interest Coverage 8.59
Cash Conversion 99.67%
Profit Quality 149.65%
Current Ratio 0.81
Quick Ratio 0.62
Altman-Z 2.17
F-Score5
WACC7.43%
ROIC/WACC0.94
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
EPS Next Y5.49%
EPS Next 2Y7.39%
EPS Next 3Y7.98%
EPS Next 5Y9.67%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%
Revenue Next Year3.24%
Revenue Next 2Y3.41%
Revenue Next 3Y3.58%
Revenue Next 5Y3.45%
EBIT growth 1Y-4.98%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year43.62%
EBIT Next 3Y17.56%
EBIT Next 5Y13.15%
FCF growth 1Y6.42%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y9.09%
OCF growth 3Y13.08%
OCF growth 5Y9.96%